1. Home
  2. FTRE vs DAWN Comparison

FTRE vs DAWN Comparison

Compare FTRE & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • DAWN
  • Stock Information
  • Founded
  • FTRE 1996
  • DAWN 2018
  • Country
  • FTRE United States
  • DAWN United States
  • Employees
  • FTRE N/A
  • DAWN N/A
  • Industry
  • FTRE Medical Specialities
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTRE Health Care
  • DAWN Health Care
  • Exchange
  • FTRE Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • FTRE 469.0M
  • DAWN N/A
  • IPO Year
  • FTRE N/A
  • DAWN 2021
  • Fundamental
  • Price
  • FTRE $5.95
  • DAWN $6.76
  • Analyst Decision
  • FTRE Hold
  • DAWN Strong Buy
  • Analyst Count
  • FTRE 11
  • DAWN 7
  • Target Price
  • FTRE $18.00
  • DAWN $31.57
  • AVG Volume (30 Days)
  • FTRE 2.3M
  • DAWN 1.3M
  • Earning Date
  • FTRE 05-12-2025
  • DAWN 05-06-2025
  • Dividend Yield
  • FTRE N/A
  • DAWN N/A
  • EPS Growth
  • FTRE N/A
  • DAWN N/A
  • EPS
  • FTRE N/A
  • DAWN N/A
  • Revenue
  • FTRE $2,696,400,000.00
  • DAWN $161,922,000.00
  • Revenue This Year
  • FTRE N/A
  • DAWN $21.25
  • Revenue Next Year
  • FTRE $3.32
  • DAWN $63.23
  • P/E Ratio
  • FTRE N/A
  • DAWN N/A
  • Revenue Growth
  • FTRE N/A
  • DAWN N/A
  • 52 Week Low
  • FTRE $4.77
  • DAWN $6.41
  • 52 Week High
  • FTRE $37.24
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 43.28
  • DAWN 40.41
  • Support Level
  • FTRE $5.40
  • DAWN $7.55
  • Resistance Level
  • FTRE $6.38
  • DAWN $7.52
  • Average True Range (ATR)
  • FTRE 0.45
  • DAWN 0.48
  • MACD
  • FTRE 0.21
  • DAWN -0.03
  • Stochastic Oscillator
  • FTRE 72.52
  • DAWN 27.32

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: